The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smyth, M. J.
Right arrow Articles by Baxter, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smyth, M. J.
Right arrow Articles by Baxter, A. G.
The Journal of Immunology, 1999, 163: 1350-1353.
Copyright © 1999 by The American Association of Immunologists

Multiple Deficiencies Underlie NK Cell Inactivity in Lymphotoxin-{alpha} Gene-Targeted Mice1

Mark J. Smyth2,*, Ricky W. Johnstone*, Erika Cretney*, Nicole M. Haynes*, Jonathon D. Sedgwick{dagger}, Heiner Korner§, Lynn D. Poulton{ddagger} and Alan G. Baxter{ddagger}

* Cellular Cytotoxicity Laboratory, The Austin Research Institute, Heidelberg, Victoria, Australia; {dagger} DNAX Research Institute of Molecular and Cellular Biology, Inc., Palo Alto, CA 94304; {ddagger} Centenary Institute of Cancer Medicine and Cell Biology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; and § Institut fuer Klinische Mikrobiologie, Immunologie und Hygiene, Erlangen, Germany

We have evaluated the NK cell antitumor activity in lymphotoxin (LT)-deficient mice. Both NK cell-mediated tumor rejection and protection from experimental metastases were significantly compromised in LT-{alpha}-deficient mice. Analysis of LT-{alpha}-deficient mice revealed that the absolute number of {alpha}{beta}TCR- NK1.1+ NK cells was reduced in bone marrow and thymus, but with overall proportional decreases in other hemopoietic organs. In addition, the antitumor potential of {alpha}{beta}TCR- NK1.1+ cells, as determined by their lytic capacity and perforin expression, was reduced 1.5- to 3-fold in LT-{alpha}-deficient mice, as compared with wild-type mice. Combined defects in NK cell development and effector function contribute to compromised NK cell antitumor function in LT-{alpha}-deficient mice.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. W. L. Teng, M. H. Kershaw, Y. Hayakawa, L. Cerutti, S. M. Jane, P. K. Darcy, and M. J. Smyth
T Cells Gene-engineered with DAP12 Mediate Effector Function in an NKG2D-dependent and Major Histocompatibility Complex-independent Manner
J. Biol. Chem., November 18, 2005; 280(46): 38235 - 38241.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Stevenaert, K. Van Beneden, V. De Colvenaer, A. S. Franki, V. Debacker, T. Boterberg, D. Deforce, K. Pfeffer, J. Plum, D. Elewaut, et al.
Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-{beta} receptor expression
Blood, August 1, 2005; 106(3): 956 - 962.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. A. Banks, S. Rickert, C. A. Benedict, L. Ma, M. Ko, J. Meier, W. Ha, K. Schneider, S. W. Granger, O. Turovskaya, et al.
A Lymphotoxin-IFN-{beta} Axis Essential for Lymphocyte Survival Revealed during Cytomegalovirus Infection
J. Immunol., June 1, 2005; 174(11): 7217 - 7225.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Brady, Y. Hayakawa, M. J. Smyth, and S. L. Nutt
IL-21 Induces the Functional Maturation of Murine NK Cells
J. Immunol., February 15, 2004; 172(4): 2048 - 2058.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G-T Ho, F M Moodie, and J Satsangi
Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?
Gut, May 1, 2003; 52(5): 759 - 766.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
M. L. VanLith, K. G. Kohlgraf, C. L. Sivinski, R. M. Tempero, and M. A. Hollingsworth
MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses
Int. Immunol., August 1, 2002; 14(8): 873 - 882.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Dohi, P. D. Rennert, K. Fujihashi, H. Kiyono, Y. Shirai, Y. I. Kawamura, J. L. Browning, and J. R. McGhee
Elimination of Colonic Patches with Lymphotoxin {beta} Receptor-Ig Prevents Th2 Cell-Type Colitis
J. Immunol., September 1, 2001; 167(5): 2781 - 2790.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
L. D. Poulton, M. J. Smyth, C. G. Hawke, P. Silveira, D. Shepherd, O. V. Naidenko, D. I. Godfrey, and A. G. Baxter
Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice
Int. Immunol., July 1, 2001; 13(7): 887 - 896.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Wu, Y. Sun, J. Wang, X. Lin, Y. Wang, L. E. Pegg, A. Futterer, K. Pfeffer, and Y.-X. Fu
Signal Via Lymphotoxin-{{beta}}R on Bone Marrow Stromal Cells Is Required for an Early Checkpoint of NK Cell Development
J. Immunol., February 1, 2001; 166(3): 1684 - 1689.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Wang, J. Wang, Y. Sun, Q. Wu, and Y.-X. Fu
Complementary Effects of TNF and Lymphotoxin on the Formation of Germinal Center and Follicular Dendritic Cells
J. Immunol., January 1, 2001; 166(1): 330 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Elewaut, L. Brossay, S. M. Santee, O. V. Naidenko, N. Burdin, H. De Winter, J. Matsuda, C. F. Ware, H. Cheroutre, and M. Kronenberg
Membrane Lymphotoxin Is Required for the Development of Different Subpopulations of NK T Cells
J. Immunol., July 15, 2000; 165(2): 671 - 679.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.